226 related articles for article (PubMed ID: 12453586)
1. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.
Oyama N; Kim J; Jones LA; Mercer NM; Engelbach JA; Sharp TL; Welch MJ
Nucl Med Biol; 2002 Nov; 29(8):783-90. PubMed ID: 12453586
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
Oyama N; Ponde DE; Dence C; Kim J; Tai YC; Welch MJ
J Nucl Med; 2004 Mar; 45(3):519-25. PubMed ID: 15001697
[TBL] [Abstract][Full Text] [Related]
3. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
4. Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.
Kukuk D; Reischl G; Raguin O; Wiehr S; Judenhofer MS; Calaminus C; Honndorf VS; Quintanilla-Martinez L; Schönberger T; Duchamp O; Machulla HJ; Pichler BJ
J Nucl Med; 2011 Oct; 52(10):1654-63. PubMed ID: 21859811
[TBL] [Abstract][Full Text] [Related]
5. Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells.
Hara T; Bansal A; DeGrado TR
Nucl Med Biol; 2006 Nov; 33(8):977-84. PubMed ID: 17127170
[TBL] [Abstract][Full Text] [Related]
6. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
[TBL] [Abstract][Full Text] [Related]
7. Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?
Emonds KM; Swinnen JV; van Weerden WM; Vanderhoydonc F; Nuyts J; Mortelmans L; Mottaghy FM
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1842-53. PubMed ID: 21732108
[TBL] [Abstract][Full Text] [Related]
8. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
[TBL] [Abstract][Full Text] [Related]
9. 18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetate.
Ponde DE; Dence CS; Oyama N; Kim J; Tai YC; Laforest R; Siegel BA; Welch MJ
J Nucl Med; 2007 Mar; 48(3):420-8. PubMed ID: 17332620
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Fricke E; Machtens S; Hofmann M; van den Hoff J; Bergh S; Brunkhorst T; Meyer GJ; Karstens JH; Knapp WH; Boerner AR
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer.
Kato T; Tsukamoto E; Kuge Y; Takei T; Shiga T; Shinohara N; Katoh C; Nakada K; Tamaki N
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1492-5. PubMed ID: 12397469
[TBL] [Abstract][Full Text] [Related]
12. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
Larson SM; Morris M; Gunther I; Beattie B; Humm JL; Akhurst TA; Finn RD; Erdi Y; Pentlow K; Dyke J; Squire O; Bornmann W; McCarthy T; Welch M; Scher H
J Nucl Med; 2004 Mar; 45(3):366-73. PubMed ID: 15001675
[TBL] [Abstract][Full Text] [Related]
13. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT
Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147
[TBL] [Abstract][Full Text] [Related]
17. [Biodistribution and positron emission tomography imaging of 11C-acetate in murine model of lung carcinoma].
Liang CY; Liu X; Zhang JM; Zhou NK; Zhang T; Liu HF
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):778-80. PubMed ID: 18683689
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC).
Henriksen G; Herz M; Hauser A; Schwaiger M; Wester HJ
Nucl Med Biol; 2004 Oct; 31(7):851-8. PubMed ID: 15464386
[TBL] [Abstract][Full Text] [Related]
19. Imaging a pancreatic carcinoma xenograft model with 11C-acetate: a comparison study with 18F-FDG.
Zhao C; Chen Z; Ye X; Zhang Y; Zhan H; Aburano T; Tian M; Zhang H
Nucl Med Commun; 2009 Dec; 30(12):971-7. PubMed ID: 19696689
[TBL] [Abstract][Full Text] [Related]
20. 11C-acetate PET imaging of prostate cancer.
Oyama N; Akino H; Kanamaru H; Suzuki Y; Muramoto S; Yonekura Y; Sadato N; Yamamoto K; Okada K
J Nucl Med; 2002 Feb; 43(2):181-6. PubMed ID: 11850482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
